Join
Live feed
·
INSIDERFilingvia Quantisnow
Connect Biopharma Holdings Limited logo

Director Xanthopoulos Kleanthis Gabriel was granted 5,000 units of Ordinary Shares, increasing direct ownership by 6% to 91,554 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CNTB· Connect Biopharma Holdings Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTB (Connect Biopharma Holdings Limited) and more on Quantisnow.